LFG
HAE icon

Larson Financial Group’s Haemonetics HAE Stock Holding History

Larson Financial Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$825 Buy
+11
New +$707 ﹤0.01% 3379
2025
Q2 		– Sell
-22
Closed -$1.4K – 3373
2025
Q1 		$1.4K Buy
+22
New +$1.5K ﹤0.01% 2285

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Larson Financial Group's HAE Position: Q2 2026 in Review

Larson Financial Group opened a new position in Haemonetics (HAE) in Q2 2026: 11 shares worth $825. The stake represents ﹤0.01% of the portfolio and ranks #3379 among its holdings. This is a return to the name: Larson Financial Group previously reported a position in HAE as recently as Q1 2025.

Larson Financial Group first reported a position in HAE in Q1 2025 and has held it in 2 quarters since. The position peaked at $1.4K in Q1 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Larson Financial Group held 11 shares of Haemonetics worth $825 as of Q2 2026.
  • Haemonetics was a new Larson Financial Group position in Q2 2026.
  • Haemonetics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3379 holding.
  • Larson Financial Group first reported a position in Haemonetics in Q1 2025 and has held it in 2 quarters since.
  • Larson Financial Group's Haemonetics position peaked at $1.4K in Q1 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.